From the ∗Department of Pathology

†Division of Hematology/Oncology, Department of Medicine, University of Maryland School of Medicine

‡University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD.

Reprints: Michael E. Kallen, MD, Department of Pathology, University of Maryland School of Medicine, 22 S Greene St, NBW-54, Baltimore, MD 21201. E-mail: [email protected].

A.E. has received research grants from Jazz Pharmaceuticals, NewLink Genetics, Amgen Inc, and Servier Pharmaceuticals. A.E. is a global oncology advisory board member for Amgen and has served as an advisory board member for Genentech, Servier, Kite, and Secura Bio. A.E. is a cofounder and scientific advisor for KinaRx Inc. The other authors have no funding or conflicts to declare.